Myriad Settles Cancer Test Patent Suits With 3 Defendants
Three of the seven companies that Myriad Genetics Inc. has accused of infringing its patents on breast cancer tests — Pathway Genomics Corp., Invitae Corp. and Laboratory Corporation of America Holdings...To view the full article, register now.
Already a subscriber? Click here to view full article